Antiglutamate Anticonvulsants in the Treatment of Alcohol Withdrawal Syndrome
Information source: St. Petersburg State Pavlov Medical University
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Topiramate; Lamotrigine; Memnatine; Diazepam; Placebo
Intervention: Anticonvulsants (Drug)
Sponsored by: St. Petersburg State Pavlov Medical University
Official(s) and/or principal investigator(s):
Evgeny M Krupitsky, MD, PhD, Principal Investigator, Affiliation: St. Petersburg State Pavlov Medical University
The study is aimed to evaluate the efficacy of antiglutamate anticonvulsants (topiramate,
lamotrigine, and memantine) in the treatment of alcohol withdrawal syndrome
Study design: Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment, Efficacy Study
Minimum age: 20 Years.
Maximum age: 60 Years.
Alcohol dependence Alcohol withdrawal syndrome
Drug dependence Major psychiatric diagnoses Severe somatic illness
Locations and Contacts
Last updated: October 17, 2006